McCall Invited Speaker at International Biobanking Conference

Shannon McCall, MD

Shannon McCall, MD, Director of the Biospecimen Repository and Processing Core (BRPC), presented a 90-minute lecture entitled  "First, Do No Harm:  Best Practices and Regulatory Requirements When Procuring Tissue Specimens in the Clinical Setting," at the International Society for Biological and Environmental Repositories (ISBER) annual meeting in Toronto, Canada on May 11, 2017.

At ISBER, Dr. McCall also hosted a roundtable discussion for “Designing the Quality Management Plan for a Hospital-based Biorepository” and delivered a platform presentation entitled “Informed Broad-consent at Duke:  Modification of ‘Boiler-plate’ Language Increases Comprehensibility and Decreases Time Burden.”   She also received an appointment to the ISBER Standards Advisory Committee.

The Duke BRPC is a tissue, blood, and fluid biorepository and research support core laboratory within the Department of Pathology.  It is a formal shared resource of both the School of Medicine and the Duke Cancer Institute.  Dr. McCall’s team has facilitated biospecimen collection and processing for over 10,000 Duke patients participating in clinical trials.  In addition, her team has obtained broad consent of over 3,500 Duke patients to donate some of their cancer tissue to research through her central biobanking resource.  The BRPC houses over 50,000 dedicated research specimens and has access to millions of leftover clinical samples that can be accessed through separate IRB approval. BRPC has been College of American Pathologists (CAP)-accredited since 2013 and has an excellent working relationship with the Clinical and Anatomic Pathology Laboratories at Duke.  This partnership supports all forms of biobanking with simultaneous protection of patient care.